Intellipharmaceutics International Stock Retained Earnings
Intellipharmaceutics International fundamentals help investors to digest information that contributes to Intellipharmaceutics' financial success or failures. It also enables traders to predict the movement of Intellipharmaceutics OTC Stock. The fundamental analysis module provides a way to measure Intellipharmaceutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intellipharmaceutics otc stock.
Intellipharmaceutics |
Intellipharmaceutics International OTC Stock Retained Earnings Analysis
Intellipharmaceutics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Intellipharmaceutics Retained Earnings | (86.55 M) |
Most of Intellipharmaceutics' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intellipharmaceutics International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Intellipharmaceutics International has a Retained Earnings of (86.55 Million). This is 109.29% lower than that of the Pharmaceuticals sector and 189.33% lower than that of the Health Care industry. The retained earnings for all United States stocks is 100.93% higher than that of the company.
Intellipharmaceutics Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intellipharmaceutics' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Intellipharmaceutics could also be used in its relative valuation, which is a method of valuing Intellipharmaceutics by comparing valuation metrics of similar companies.Intellipharmaceutics is currently under evaluation in retained earnings category among its peers.
Intellipharmaceutics Fundamentals
| Return On Asset | -0.98 | |||
| Operating Margin | (106.06) % | |||
| Current Valuation | 4.47 M | |||
| Shares Outstanding | 33.09 M | |||
| Shares Owned By Insiders | 1.70 % | |||
| Shares Owned By Institutions | 11.09 % | |||
| Number Of Shares Shorted | 714 K | |||
| Price To Earning | (0.50) X | |||
| Price To Sales | 66.19 X | |||
| Gross Profit | 1.4 M | |||
| EBITDA | (4.45 M) | |||
| Net Income | (5.15 M) | |||
| Cash And Equivalents | 79.65 K | |||
| Total Debt | 2.01 M | |||
| Debt To Equity | 165.20 % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (0.31) X | |||
| Cash Flow From Operations | (2.46 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.16) X | |||
| Target Price | 25.0 | |||
| Number Of Employees | 11 | |||
| Beta | 1.0 | |||
| Market Capitalization | 2.02 M | |||
| Total Asset | 2.1 M | |||
| Retained Earnings | (86.55 M) | |||
| Working Capital | (5.62 M) | |||
| Current Asset | 1.41 M | |||
| Current Liabilities | 7.02 M | |||
| Z Score | -65.8 | |||
| Net Asset | 2.1 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |